Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains

被引:5
作者
Andersson, HA
Singh, RAK
Barry, MA
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Houston, TX 77030 USA
[3] Methodist Hosp, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[6] Rice Univ, Dept Bioengn, Houston, TX 77030 USA
关键词
HCV; core protein; hydrophobicity; ubiquitin; proteasome; genetic immunization; vaccine; cellular immunity;
D O I
10.1016/j.ymthe.2005.09.005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis C virus (HCV) is the major pathogen of chronic hepatitis and liver disease, but currently there are no prophylactic HCV vaccines available. The HCV core protein-encoding sequence is among the most conserved genes in the HCV genome, making it a prime candidate for a component of a vaccine. The core protein localizes to the endoplasmic reticulum (ER) through a C-terminal hydrophobic region that is cotranslationally inserted into the ER membrane. Here we show that removal of the C-terminal hydrophobic region confers nuclear localization and enhances proteasomal degradation of the core protein in mammalian cells. This efficient protein proteolysis induces enhanced core-specific CD8(+) T cell responses in BALB/c mice immunized with plasmids expressing C-terminal deletions of the HCV core protein. These results suggest that more potent HCV vaccines can be achieved by targeting the core protein for proteasomal degradation by deletion of its C-terminal hydrophobic domain.
引用
收藏
页码:338 / 346
页数:9
相关论文
共 52 条
[11]   DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity [J].
Delogu, G ;
Howard, A ;
Collins, FM ;
Morris, SL .
INFECTION AND IMMUNITY, 2000, 68 (06) :3097-3102
[12]  
Eisen G, 1904, HARRIMAN ALASKA EXPE, V12, P1, DOI DOI 10.5962/BHL.TITLE.11673
[13]   Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens [J].
Fu, TM ;
Guan, LM ;
Friedman, A ;
Ulmer, JB ;
Liu, MA ;
Donnelly, JJ .
VACCINE, 1998, 16 (18) :1711-1717
[14]   Type 1 interferon augments DNA-based vaccination against hepatitis C virus core protein [J].
Gehring, S ;
Gregory, SH ;
Kuzushita, N ;
Wands, JR .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) :249-257
[15]  
Geissler M, 1997, J IMMUNOL, V158, P1231
[16]   EXPRESSION AND IDENTIFICATION OF HEPATITIS C VIRUS POLYPROTEIN CLEAVAGE PRODUCTS [J].
GRAKOUI, A ;
WYCHOWSKI, C ;
LIN, C ;
FEINSTONE, SM ;
RICE, CM .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1385-1395
[17]  
GRANT EP, 1995, J IMMUNOL, V155, P3750
[18]   Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C [J].
Grüner, NH ;
Gerlach, TJ ;
Jung, MC ;
Diepolder, HM ;
Schirren, CA ;
Schraut, WW ;
Hoffmann, R ;
Zachoval, R ;
Santantonio, T ;
Cucchiarini, M ;
Cerny, A ;
Pape, GR .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1528-1536
[19]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[20]   GENE-MAPPING OF THE PUTATIVE STRUCTURAL REGION OF THE HEPATITIS-C VIRUS GENOME BY INVITRO PROCESSING ANALYSIS [J].
HIJIKATA, M ;
KATO, N ;
OOTSUYAMA, Y ;
NAKAGAWA, M ;
SHIMOTOHNO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5547-5551